Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy
Clinical trial NCT05000710 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05000710
- Sponsor
- Sheba Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2026-12-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.